The Nuclear Technologies in Medicine and the Biosciences Initiative (NTeMBI), a national technology platform, is managed by Necsa and supported by the Department of Science and Technology (DST). During 2010, the DST approved an updated three year Business Plan developed by Necsa.
NTeMBI functions as a high level Research, Development and Innovation (RD&I) initiative providing a framework to consolidate expertise and to implement new strategic initiatives relating to R&D on nuclear technologies in medicine and the biosciences on a local, regional and international level.
It is envisaged that this will lead to the development of significant additional RD&I capacity in South Africa and the introduction of new products and services into the African and international markets.
Funding received will be used during subsequent years largely to implement NTeMBI projects designed through national workshops and included in the updated Business Plan.
The projects address high priority areas in the development of new nuclear medicine diagnostics and therapeutics for cancer as well as communicable diseases. NTeMBI will also seek to make a contribution to the malaria control programme through supporting a project aimed at assessing the Sterile Insect Technique for mosquitoes.